Aldeyra Therapeutics
ALDX
NZ$7.23
Share price
1.16%
Change (1 day)
33.90%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$49.18 Million
According to Aldeyra Therapeutics 's latest financial reports the company's total liabilities are NZ$49.18 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aldeyra Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$59.58 M | 32.06% |
| 2023-12-31 | NZ$45.11 M | -5.41% |
| 2022-12-31 | NZ$47.69 M | 18.9% |
| 2021-12-31 | NZ$40.11 M | 21.4% |
| 2020-12-31 | NZ$33.04 M | -18.88% |
| 2019-12-31 | NZ$40.73 M | 222.5% |
| 2018-12-31 | NZ$12.63 M | 96.14% |
| 2017-12-31 | NZ$6.44 M | 26.1% |
| 2016-12-31 | NZ$5.1 M | 5.09% |
| 2015-12-31 | NZ$4.86 M | 52.14% |
| 2014-12-31 | NZ$3.19 M | -53.51% |
| 2013-12-31 | NZ$6.87 M | -79.16% |
| 2012-12-31 | NZ$32.98 M | 892.52% |
| 2011-12-31 | NZ$3.32 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | NZ$13.55 B | 27,462.16% | 🇺🇸 USA |